iifl-logo

Gland Pharma Ltd Historical Data

Add as a Preferred Source on Google
2,360.9
(1.99%)
Jun 29, 2026|05:24:56 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Gland Pharma Ltd Historical Data

29/05/2026calendar-icon
29/06/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

01-Jun-2026

2,278.6

2,356.52,255.82,292.449,0701,35,26,61,817.52,74,419

02-Jun-2026

2,268.9

2,337.52,263.22,27731,5751,10,67,14,827.33,01,994

03-Jun-2026

2,277

2,305.92,2222,232.321,60057,82,87,203.51,25,012

04-Jun-2026

2,221.2

2,276.72,2122,219.527,63945,75,32,260.798,665

05-Jun-2026

2,232.8

2,288.32,1962,27343,9921,11,15,92,468.12,14,704

08-Jun-2026

2,269.1

2,3362,2372,247.841,0551,08,60,64,933.11,53,648

09-Jun-2026

2,257

2,314.92,256.92,288.532,5931,19,48,11,0103,15,056

10-Jun-2026

2,299

2,341.52,2502,267.825,37173,69,70,380.91,35,858

11-Jun-2026

2,243

2,3952,215.42,306.51,72,0375,66,35,08,797.99,56,196

12-Jun-2026

2,311.5

2,3542,2502,262.254,4191,59,30,83,908.93,23,767

15-Jun-2026

2,313.2

2,313.22,1902,213.142,1991,23,52,33,428.52,55,795

16-Jun-2026

2,218

2,230.82,1682,178.747,9971,11,90,87,431.32,85,471

17-Jun-2026

2,199.8

2,210.32,167.82,197.628,1081,86,24,27,962.66,17,699

18-Jun-2026

2,200

2,269.92,193.82,202.247,2372,24,47,39,801.77,12,520

19-Jun-2026

2,209

2,229.52,1852,19927,89963,25,50,175.41,70,100

22-Jun-2026

2,180

2,2242,179.92,186.752,8671,17,25,25,4543,49,720

23-Jun-2026

2,193.3

2,3072,1852,298.21,54,9564,72,97,82,597.59,02,491

24-Jun-2026

2,300

2,3482,287.92,326.266,2112,20,44,62,338.94,61,185

25-Jun-2026

2,347

2,369.52,303.22,314.844,4251,31,44,92,719.82,66,208

Gland Pharma: Related NEWS

Gland Pharma Stock Gains 7% as Q3 Revenue Climbs 22.5% to ₹1,695.3 Crore

The European business reported a 54 percent year on year surge in topline during the quarter.

29 Jan 2026|12:20 PM
Read More
Top Stocks for Today - 8th January 2026

Here are some of the stocks that may see significant price movement today: Infosys, Tata Steel, Cipla Limited, etc.

8 Jan 2026|07:31 AM
Read More
Top Stocks for Today - 4th November 2025

Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.

4 Nov 2025|08:01 AM
Read More
Top Stocks for Today - 14th July 2025

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

14 Jul 2025|06:30 AM
Read More
Gland Pharma Gets USFDA Clearance for Visakhapatnam Facility

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

25 Jun 2025|12:07 PM
Read More
Top Stocks for Today - 5th June 2025

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

5 Jun 2025|07:53 AM
Read More
Gland Pharma gets USFDA approval for blood pressure drug

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

4 Jun 2025|03:34 PM
Read More
Gland Pharma Q4 Net Profit Declines 3.1% to ₹186.5 Crore; Revenue Down 7.3% YoY

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

22 May 2025|08:49 AM
Read More
Gland Pharma Gets USFDA Nod for Glaucoma Drug

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

30 Apr 2025|03:40 PM
Read More
USFDA Issues Three Observations to Gland Pharma's Visakhapatnam Facility

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.

26 Feb 2025|12:22 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.